PUBLISHER: The Business Research Company | PRODUCT CODE: 1942614
PUBLISHER: The Business Research Company | PRODUCT CODE: 1942614
Contraceptive devices are medical tools designed to prevent pregnancy. They come in various forms, each with distinct mechanisms and levels of effectiveness. These devices are primarily used to avoid unintended pregnancies and, in some cases, offer protection against sexually transmitted infections (STIs).
The main types of contraceptive devices include male contraceptive devices, female contraceptive devices, female condoms, diaphragms and sponges, vaginal rings, intrauterine devices, sub-dermal implants, and others. Male contraceptive devices, such as condoms and vasectomy procedures, are methods used by men to prevent pregnancy. They include both hormonal and barrier methods. These devices are distributed through various channels, including hospital pharmacies, retail pharmacies, clinics, online platforms, public channels, non-governmental organizations (NGOs), and others.
Tariffs are impacting the contraceptive devices market by increasing costs for imported medical-grade polymers, latex, hormones, and precision manufacturing components used in condoms, iuds, implants, and vaginal rings. These cost pressures have particularly affected long-acting and implantable contraceptive segments, with asia-pacific and north america experiencing higher exposure due to global supply chain dependence. Higher tariffs have influenced pricing across retail and public distribution channels. However, tariffs have also encouraged local manufacturing, regional sourcing, and public-sector procurement initiatives, supporting long-term supply stability.
The contraceptive devices market research report is one of a series of new reports from The Business Research Company that provides contraceptive devices market statistics, including contraceptive devices industry global market size, regional shares, competitors with a contraceptive devices market share, detailed contraceptive devices market segments, market trends and opportunities, and any further data you may need to thrive in the contraceptive devices industry. This contraceptive devices market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.
The contraceptive devices market size has grown strongly in recent years. It will grow from $13.55 billion in 2025 to $14.4 billion in 2026 at a compound annual growth rate (CAGR) of 6.3%. The growth in the historic period can be attributed to rising awareness of family planning methods, government-supported population control programs, increasing prevalence of unintended pregnancies, expansion of reproductive health services, growing availability of over-the-counter contraceptive products.
The contraceptive devices market size is expected to see strong growth in the next few years. It will grow to $18.31 billion in 2030 at a compound annual growth rate (CAGR) of 6.2%. The growth in the forecast period can be attributed to increasing focus on reproductive autonomy and women's health, rising demand for long-term and low-maintenance contraception, expansion of digital health and online pharmacy platforms, growing adoption of male contraceptive solutions, increasing public and ngo-led sexual health initiatives. Major trends in the forecast period include rising adoption of long-acting reversible contraceptives, increasing demand for female-controlled contraceptive options, growing acceptance of non-hormonal contraceptive devices, expansion of contraceptive access through online and public channels, increasing focus on dual protection against pregnancy and stis.
The increasing prevalence of sexually transmitted diseases (STDs) is expected to drive growth in the contraceptive device market. STDs are infections primarily spread through sexual contact, affecting various body parts and potentially causing a range of symptoms and health issues. Rising STD rates are linked to factors such as higher sexual activity, inadequate protection, insufficient sexual health education, and difficulties accessing healthcare and testing. Contraceptive devices, particularly condoms, are essential for preventing STDs as they create a barrier that reduces the risk of transmission by preventing direct contact with infectious fluids and lesions. For example, a report by the UK Health Security Agency in July 2024 noted 401,800 new STI diagnoses in England in 2023, a 4.7% increase from the previous year's 383,789 cases. Gonorrhoea diagnoses rose by 7.5%, from 79,268 in 2022 to 85,223 in 2023, while infectious syphilis diagnoses increased by 9.4%, from 8,693 in 2022 to 9,513 in 2023. This growing prevalence of STDs is driving demand for contraceptive devices.
Companies in the contraceptive device market are focusing on developing innovative products, such as contraceptive vaginal rings, to offer convenient, low-maintenance birth control with a once-a-month insertion. A contraceptive vaginal ring is a flexible, hormone-releasing device placed in the vagina, which prevents pregnancy by continuously releasing hormones to inhibit ovulation and thicken cervical mucus. For instance, in October 2023, Xiromed LLC, a US-based pharmaceutical company, introduced the EnilloRing. This contraceptive vaginal ring, developed by Xiromed, combines etonogestrel and ethinyl estradiol and is designed for long-term use, remaining in place for three weeks, followed by a one-week ring-free interval.
In December 2023, Aditxt, a US-based life sciences company, acquired Evofem Biosciences for $100 million. This acquisition includes Evofem's FDA-approved hormone-free contraceptive gel, Phexxi(R) (lactic acid, citric acid, and potassium bitartrate). Aditxt aims to use this acquisition to bolster its focus on innovations in autoimmunity, health metrics, life-extending transplant technologies, population health, and women's health. This acquisition enhances Aditxt's collaborative ecosystem and maximizes the potential of its subsidiaries. Evofem Biosciences is a US-based manufacturer of contraceptive devices.
Major companies operating in the contraceptive devices market are Pfizer Inc., Johnson & Johnson Services Inc., Bayer AG, Teva Pharmaceutical Industries Ltd., Mylan N.V., Organon Group, Hologic Inc., CooperSurgical Inc., Cipla Inc., Mankind Pharma Ltd., TTK HealthCare Ltd., Merck Sharp & Dohme Corp., Evofem Biosciences Inc., Veru Inc., Agile Therapeutics Inc., Janssen Global Services LLC, HLL Lifecare Ltd., Mayer Laboratories Inc., V-Care Pharma Pvt. Ltd., Vardhaman Lifecare Pvt. Ltd., Actavis Pharma LLC, Pregna International Limited
North America was the largest region in the contraceptive devices market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the contraceptive devices market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
The countries covered in the contraceptive devices market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain
The contraceptive devices market consists of sales of cervical caps, hormonal injections, emergency contraceptive devices and sterilization products. Values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.
The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).
The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.
Contraceptive Devices Market Global Report 2026 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.
This report focuses contraceptive devices market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.
Where is the largest and fastest growing market for contraceptive devices ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The contraceptive devices market global report from the Business Research Company answers all these questions and many more.
The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, total addressable market (TAM), market attractiveness score (MAS), competitive landscape, market shares, company scoring matrix, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.
Added Benefits available all on all list-price licence purchases, to be claimed at time of purchase. Customisations within report scope and limited to 20% of content and consultant support time limited to 8 hours.